Celtaxsys' discovery program has moved rapidly from one focused on pathway discovery to target characterization and lead identification. Five independent disease areas are being pursued simultaneously to interrogate therapeutic opportunities for modulation of immune cell migration.
Home
Management
Technology
Pipeline
Careers
Contact
Privacy Policy
Terms of Use
